VNDA

Vanda Pharmaceuticals Inc.

Price

$5.57

return (12m)

22.96%

p/e

-1.11

p/bv

1.39

DIVIDEND YIELD

0.00%

VNDA price

Vanda Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VNDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.30%

3 months

-10.31%

1 year

22.96%

2 years

4.11%

5 years

-64.77%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VNDA

Valuation

P/E

-1.11

Sector -4.38

Industry -4.38

P/BV

1.39

Sector 2.02

Industry 2.02

P/Revenue (PSR)

1.42

Sector -4.40

Industry -4.40

EV/EBITDA

-2.26

Sector -263.09

Industry -263.09

EV/EBIT

-2.13

Sector -702.90

Industry -702.90

P/EBITDA

-1.79

Sector -4.39

Industry -4.39

P/EBIT

-1.65

Sector -4.73

Industry -4.73

P/Total Assets

0.74

Sector 1.49

Industry 1.49

P/Net Current Assets

4.24

Sector -11.70

Industry -11.70

P/Working Capital

3.05

Sector -3.19

Industry -3.19

EPS

-4.58

Sector -2.14

Industry -2.14

BVPS

3.67

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

93.73%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-118.94%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-126.28%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-86.06%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.12

Sector 0.03

Industry 0.03

Profitability

ROE

-124.83%

Sector -65.14%

Industry -65.14%

ROA

-66.64%

Sector -65.53%

Industry -65.53%

ROIC

-105.74%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.61

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.83

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.66

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.77

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.53

Sector 0.41

Industry 0.41

Liabilities/Assets

0.47

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-4.29%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals VNDA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VNDA Vanda Pharmaceuticals Inc.	$5.57	22.15%	0.00%	-1.11	1.39	-124.83%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VNDA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

24 years

Founded: 2002

2006

Time since IPO - 20 years

292

Employees

Vanda Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $306.00 million, with shareholders equity totaling $220.19 million.

The company employs approximately 292 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vanda Pharmaceuticals Inc. reported $215.73 million in revenue, generating net income of $-274.86 million.

Key financial metrics include a P/E ratio of -1.11, a price-to-book (P/B) ratio of 1.39, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VNDA.

Market cap

$306.00 million

Net worth

$220.19 million

$220,190,000.00

Assets

$412.47 million

$412,470,000.00

Total Shares Outstanding

60.00 million

60,000,000

Average Daily Trading Volume

$953.91 Thousand

$953,908.00

Sector

Health Care

Industry

Biotechnology

VNDA

VNDA revenue and profits

Financial Results VNDA

DRAG THE FRAME TO SEE MORE DATA

VNDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Vanda Pharmaceuticals (VNDA) today?

A cotação de Vanda Pharmaceuticals (VNDA) hoje está em US$ 5.57, com uma variação de 22.96% em relação ao último ano. A cotação de Vanda Pharmaceuticals (VNDA) iniciou o ano negociando na casa dos US$ 8.82 e hoje está em US$ 5.57. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Vanda Pharmaceuticals (VNDA) e dados de ações do Ibovespa e mercados internacionais.

Quando Vanda Pharmaceuticals (VNDA) paga dividendos?

Vanda Pharmaceuticals (VNDA) não distribuiu dividendos no último ano.

Is Vanda Pharmaceuticals (VNDA) a good investment?

Atualmente, Vanda Pharmaceuticals (VNDA) está cotada a US$ 5.57, com um P/L de -1.11, representando um desvio de 2,941% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 22.96 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 22.96%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vanda Pharmaceuticals (VNDA) stock?

Investir em ações de Vanda Pharmaceuticals (VNDA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Vanda Pharmaceuticals (VNDA) yield today?

A rentabilidade de Vanda Pharmaceuticals (VNDA) foi de 2.30% no último mês, 22.96% no último ano e -64.77% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Vanda Pharmaceuticals (VNDA) hoje, o investimento total seria de US$ 557.00, com base na cotação atual de US$ 5.57.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 684.89
Em 5 anos: US$ 196.23
Em 10 anos: US$ 557.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VNDA

Vanda Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VNDA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING VNDA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc.

United States

24 years

2006

292

PROFIT X PRICE VNDA

Financial Results VNDA

VNDA cash flow

Asset, Revenue and Profit Growth - VNDA

VNDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions